VALIDATE Industry Seminar: Addressing Pathogen and Human Diversity
Yesterday, over 30 people joined VALIDATE on MS teams to hear our latest Industry Seminar from Graham Clarke, Chair of immBio.
ImmBio is developing next-generation vaccines against serious infectious disease targets. In the seminar, Graham talked about how variable human immune responses highlights the need in vaccinology to identify and develop technologies that are able to address diversity.
Industry Seminar - Watch now!
You can watch Graham's seminar and our previous Industry Seminar, Capturing and recreating recombinant polyclonal antibodies with Dr Sheila Keating of Gigagen, on the VALIDATE YouTube Channel.
- The PASIFIC Fellowship Programme - A unique opportunity for researchers who want to undertake state-of-the-art research in a dynamic scientific environment - 15 June 2021
- NIH Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research, 2020-2022 - To support projects that utilise open-access data to address knowledge gaps in basic/clinical research of infectious disease - 16 June 2021
- MRC Clinical Research Training Fellowships, 2021 - Supports clinicians to undertake a PhD or other higher research degree - 1 September 2021
- MRC Clinician Scientist Fellowship (CSF) - For doctors, dentists, nurses, midwives, AHP (& some vets) to establish their own research group - 1 September 2021
This is only a small selection of the external funding we have listed and you can find more on our external funding page.
Training Opportunities and Events:
- 13th Latin American and Caribbean Congress of Immunology 2021, Varadero, Cuba, 1 November 2021
- British Society for Immunology Congress 2021, Edinburgh, UK, 28 November 2021
More opportunities can be found on our Training and Events pages.
Clinical Postdoctoral Fellow - PhD, Seattle Children's Hospital, WA USA, no stated deadline.
There are many more relevant career opportunities on our jobs page.
- A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine, Brook B et al, in Vaccine
- OXSR1 inhibits inflammasome activation by limiting potassium efflux during mycobacterial infection, Hortle E et al, in bioRxiv
- Immediate Bacille Calmette-Guérin vaccination to neonates requiring perinatal treatment at the maternity ward in Guinea-Bissau: A randomized controlled trial, Schaltz-Buchholzer F et al, in The Journal of Infectious Disease
- Timing of Mycobacterium tuberculosis exposure explains variation in BCG effectiveness: a systematic review and meta-analysis, Trauer JM et al, in Thorax
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
We continued our #BCG100Facts with an infographic about TB and fashion and shared Frontiers in Immunology's calls for contributions to their Women of Immunology topic. The Global Forum on TB Vaccines celebrated the end of a successful Working Group on TB Vaccines and shared a video calling for a world free of TB. The EU Commission's Director of Health & Food Safety shared a video focusing on the 200 non-covid vaccines that have saved billions of lives and TBPPM were asking how the TB community can support health systems during the current wave of COVID. Write that PhD has some excellent advice for writing a discussion & conclusion, how to report results and develop an argument, and how to refer to literature in research writing. Nature careers had some advice for writing a Personal Statement and for ECRs looking to land a leadership role in research. VALIDATE member Heidi Larson advised journalists on how they can fight vaccine disinformation.
Following @NetworkVALIDATE on Twitter is the best way to keep up to date. You can also take part in BCG100 by using the hashtag #BG100.
Published: 28 April 2021